% | $
Quotes you view appear here for quick access.

Arena Pharmaceuticals, Inc. Message Board

  • bioimmunomabman bioimmunomabman Nov 7, 2013 4:07 PM Flag


    Under the terms of the agreement, Arena will receive from Eisai an upfront
    payment of $60 million and is eligible to receive up to a total of $176.5
    million in regulatory and development milestone payments. The total for
    milestone payments represents an increase of $123 million from the amount
    remaining available under the previous agreement.

1.59+0.02(+1.27%)11:12 AMEDT